Point72 (Difc) LTD Bristol Myers Squibb CO Call Options Transaction History

Point72 (Difc) LTD

  • $2.95 Trillion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $9.94 Million - $13 Million
250,600 Added 392.18%
314,500 $16.3 Billion
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $1.23 Million - $1.62 Million
30,600 Added 91.89%
63,900 $2.65 Billion
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $1.6 Million - $1.81 Million
33,300 New
33,300 $1.81 Billion

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email